Ovid Therapeutics

Last update: May 15, 2020

United States (USA) Its 14 main executives

Recent executive movements at Ovid Therapeutics

Jason Tardio has joined the company as Chief Commercial Officer  (news posted on November 19 2019).

Create an alert
to follow the executive moves at Ovid Therapeutics.

Latest M&A news in Biotechnology.

JW Therapeutics has announced the acquisition of Eureka Therapeutics (posted on Jul 20, 2020).
Alexion Pharmaceuticals has acquired Portola Pharmaceuticals (posted on Jul 2, 2020).
Pionyr Immunotherapeutics and Gilead Sciences have announced they will merge (posted on Jun 23, 2020).

Ovid Therapeutics is one of the...

The most constantly updated executive directory.



Learn about your clients' org charts. Understand their industries and their competitors.



View the executives' biographies. Contact the executives through our email platform.



Select key words to follow your clients. Receive alerts when executive movements happen.


Track your clients

File your clients in folders. Add private notes. Download our data in Excel on your PC.